Final Close Approaching: Inside PhyCap
Webinar Overview
PhyCap will hold its final close on June 1.
If you’re a physician, healthcare operator, or investor considering getting involved, this session is designed to give you a clear understanding of how the fund works and what participation actually looks like before the close.
Most healthtech companies don’t fail because of the technology. They fail because they don’t get used in practice.
That gap between what looks promising and what actually works is where we spend most of our time.
PhyCap was built to address that, bringing physicians and healthcare operators into the investment process earlier, where their insight can shape what gets funded and what ultimately gets adopted.
Over the past two webinars, we opened up our process through a live deal debate and shared the patterns we see after reviewing hundreds of opportunities.
This final session brings it together and focuses on how to get involved.
What You’ll Learn
How PhyCap approaches early-stage healthcare investing
Why clinical insight plays a critical role in evaluating new technologies
Where physicians and operators participate beyond capital
What we’ve learned from reviewing hundreds of healthtech opportunities
What to expect ahead of the June 1 final close
Why This is Different
Most clinicians are asked to advise after companies are already built.
PhyCap creates an opportunity to be involved earlier, where clinical insight can influence which companies are funded and how opportunities are evaluated.
This is not a theoretical discussion or a general overview of venture capital.
It’s a practical look at how the fund works, how decisions are made, and how participants engage in the process.
Who This Is For
Physicians interested in healthcare innovation and venture investing
Healthcare operators and executives looking for exposure to early-stage healthtech
Accredited investors considering participation before the final close
Prior attendees who want a clearer picture of how to get involved
Important Timing
PhyCap’s final close is June 1.
We’re now in the final phase of bringing in investors, with limited capacity remaining.
If you’re considering getting involved, this will be one of the last opportunities to hear directly from the team before the close.
This session will be recorded. If you can't make it live, register to receive the recording.
About the Speakers
Paul Slosar, MD, MHCDS is an orthopedic spine surgeon who practiced for 28 years, including 13 years as president and administrative partner, in the San Francisco Bay area. Dr. Slosar also has extensive experience as a Health Tech operator and advisor with multiple successful exits. He currently works full-time as a med-tech executive and strategic consultant for healthcare companies. Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Certificate in Value-Based Health Care from Harvard Business School.
Vipul Kella, MD is a board-certified emergency physician who has been practicing for two decades in the Washington D.C. area. He has spent over a decade as a hospital executive, focusing on innovations in quality improvement and patient safety. He has consulted with several Fortune 500 companies and hospital systems in areas of operational improvement and healthcare strategy. He is currently the Chief Medical Officer of a pre-market wearables company in the remote physiological monitoring (RPM) space.
Tracy Poole is an attorney with over 30 years of experience in complex commercial transactions, M&A, financing, energy, hedge fund and venture capital disciplines. Tracy was corporate and outside counsel to leading energy marketing and trading companies and helped close some of the largest wholesale energy transactions in existence. He is the former General Counsel of a large energy-related hedge fund and the founder and operator of an independent upstream oil and gas producer with multiple exits. Tracy has been investing in early-stage companies for more than 20 years.